HOME >> MEDICINE >> NEWS
Anti-Depressant Drug Shows Promise As Weight-Loss Treatment

g during the first eight weeks appear to be losing additional weight as the treatment is continued past the six-month mark, said Gadde, although researchers have not completed analysis of these data yet. "Here we have a well-tolerated drug that has shown significant clinical benefits in reducing weight," Gadde said. "While we have to approach the results cautiously because the long-term results are not completed, we are very excited about the potential this drug has for treating obesity."

A newer-generation anti-depressant, bupropion SR is in a class by itself and has no appreciable effect on the brain chemical serotonin, as do the majority of newer anti-depressants. Bupropion SR works by increasing available amounts of norepinephrine and dopamine, two other brain chemicals implicated in the reward and pleasure pathways.

Gadde says its unique mechanism of action may account for why patients remark that bupropion does not suppress their appetite, but rather helps them feel satisfied more easily. "A lot of patients have said that, while on the drug, they can eat a small piece of pie and feel satisfied, although not necessarily full. So it appears they feel rewarded much quicker than they normally do without the drug." The only side effect commonly reported in this study was dry mouth. Burpopion SR is not approved by the FDA for weight loss and should not be used by patients with seizure disorders, anorexia or bulimia, Gadde said.

The study will continue for another 18 months. Data also are being collected on bone density and lean muscle mass. Preliminary results should be available later this summer.


'"/>

Contact: Rebecca Levine
Levin005@mc.duke.edu
919-684-4148
Duke University Medical Center
18-May-1999


Page: 1 2

Related medicine news :

1. Study Finds Psychotherapy And Anti-Depressants Equally Effective In Treating Severely Depressed Primary-Care Patients
2. Anti-Depressants: Miracle Drugs Or Placebos With A Buzz?
3. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
4. Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction
5. Research Shows That Noncompliance Is Responsible For Half The Cases Of Nonresponse To Antihypertensive Drug Treatment
6. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
7. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
8. Evidence Shows Drug-Psychotherapy Combo Effective For Chronic Depression
9. Research Shows Religion Plays A Major Role In Health, Longevity
10. Balloon Procedure In The Brain? Longest Follow-Up To Date Shows Good Results
11. Study Shows Dermatologists Are Best At Removing Skin Cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump ... preparing for how his administration could impact the employee benefits industry. James Slotnick, ... are most likely to make it through Congress. His discussion will focus on ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing enhancements ... their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered nurses ... as 16 months and for as little as $14,528. These changes will enable nurses ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ... ... at US$ 7,167.6 Mn in 2015, and is expected to ... of 5.6% from 2016 to 2024. The ...
Breaking Medicine Technology:
Cached News: